Media headlines about Genesis Healthcare (NYSE:GEN) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Genesis Healthcare earned a news impact score of 0.18 on Accern’s scale. Accern also gave news coverage about the company an impact score of 44.2659237199907 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

Shares of Genesis Healthcare (NYSE:GEN) opened at $1.24 on Monday. Genesis Healthcare has a 1 year low of $0.60 and a 1 year high of $3.20. The company has a market capitalization of $193.94, a PE ratio of -0.25 and a beta of 1.11. The company has a debt-to-equity ratio of -0.22, a quick ratio of 0.18 and a current ratio of 0.18.

TRADEMARK VIOLATION NOTICE: This news story was reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with's FREE daily email newsletter.